Based on the Sinopharm Tech Holdings Ltd stock forecast from 0 analysts, the average analyst target price for Sinopharm Tech Holdings Ltd is not available over the next 12 months. Sinopharm Tech Holdings Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Sinopharm Tech Holdings Ltd is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Sinopharm Tech Holdings Ltd’s stock price was HKD 0.10. Sinopharm Tech Holdings Ltd’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -32.88% over the last year.
No recent analyst target price found for Sinopharm Tech Holdings Ltd
No recent average analyst rating found for Sinopharm Tech Holdings Ltd
Company Overview Sinopharm Tech Holdings Ltd
Sinopharm Tech Holdings Limited, an investment holding company, engages in lottery business in the People's Republic of China and Hong Kong. It operates through Provision of Lottery-Related Services, Provision of Internet Plus Services, and Manufacturing and Distribution of Personal Protective Equipment segments. The company offers lottery-related hardware and software systems. It also involved in the provision of Internet plus solution services; and supply chain management, data analysis, and related services, as well as trading of goods through internet platform. In addition, the company offers corporate management services; and manufactures and distributes personal protective equipment and consumables. The company was formerly known as China Vanguard You Champion Holdings Limited and changed its name to Sinopharm Tech Holdings Limited in June 2019. Sinopharm Tech Holdings Limited was founded in 1999 and is headquartered in Central, Hong Kong. Read Less
Sinopharm Tech Holdings Limited, an investment holding company, engages in lottery business in the People's Republic of China and Hong Kong. It operates through Provision of Lottery-Related Services, Provision of Internet Plus Services, and Manufacturing and Distribution of Perso...Read More
Frequently Asked Questions About Sinopharm Tech Holdings Ltd (8156:HK) Stock
Stock Target Advisor's fundamental analysis for Sinopharm Tech Holdings Ltd's stock is Slightly Bearish.
Unfortunately we do not have enough data on 8156:HK's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 8156:HK's stock to indicate what its average analyst target is.
8156:HK stock's Price/Earning ratio is 9.10.
Our analysis grades 8156:HK stock's Price / Earning ratio at D+. This means that 8156:HK stock's Price/Earning ratio is above 32.99999999999999% of the stocks in the Software - Application sector in the HK exchange.
Based on this 8156:HK may be fairly valued for its sector
The last closing price of 8156:HK's stock was HKD 0.10.
The most recent market capitalization for 8156:HK is HKD 0.06B.
Unfortunately we do not have enough analyst data on 8156:HK's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Sinopharm Tech Holdings Ltd's stock.
As per our most recent records Sinopharm Tech Holdings Ltd has 18 Employees.
Sinopharm Tech Holdings Ltd's registered address is Ruttonjee House, Central, Hong Kong.
You can get more information about it from Sinopharm Tech Holdings Ltd's website at https://www.sinopharmtech.com.hk.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About Sinopharm Tech Holdings Ltd (8156:HK) Stock
Stock Target Advisor's fundamental analysis for Sinopharm Tech Holdings Ltd's stock is Slightly Bearish.
Unfortunately we do not have enough data on 8156:HK's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 8156:HK's stock to indicate what its average analyst target is.
8156:HK stock's Price/Earning ratio is 9.10.
Our analysis grades 8156:HK stock's Price / Earning ratio at D+. This means that 8156:HK stock's Price/Earning ratio is above 32.99999999999999% of the stocks in the Software - Application sector in the HK exchange.
Based on this 8156:HK may be fairly valued for its sector
The last closing price of 8156:HK's stock was HKD 0.10.
The most recent market capitalization for 8156:HK is HKD 0.06B.
Unfortunately we do not have enough analyst data on 8156:HK's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Sinopharm Tech Holdings Ltd's stock.
As per our most recent records Sinopharm Tech Holdings Ltd has 18 Employees.
Sinopharm Tech Holdings Ltd's registered address is Ruttonjee House, Central, Hong Kong.
You can get more information about it from Sinopharm Tech Holdings Ltd's website at https://www.sinopharmtech.com.hk.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 8156:HK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
